Clinical Trial Update: A Study to Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]

View source ↗

Summary

Early-stage study evaluating mitoxantrone hydrochloride liposome injections with cytarabine in treatment-naive or relapsed/refractory acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Mitoxantrone Hydrochloride Liposome Injection (mitoxantrone hydrochloride liposome)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Treatment-naive or Relapsed or Refractory Acute Myeloid Leukemia (AML) | Phase 1, Phase 2 | Status: UNKNOWN